Dhooria, S. et al. 2020. A real-world study of the tolerability and dosing of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis: Pirfenidone dose and survival in IPF. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 37, 2 (Jun. 2020), 148–157. DOI:https://doi.org/10.36141/svdld.v37i2.8718.